Merck & Co., Inc. to Spend $120M to Convert Schering-Plough Corporation N.J. Headquarters into Biologics Research Center; Will Cause 580 Layoffs -- Merck plans to spend $120 million over the next two years to transform Schering-Plough’s former world headquarters in Kenilworth into a research center heavily focused on discovering and developing biologics — potent medicines made of proteins and human antibodies.

Back to news